Cargando…

Use of the moving epidemic method (MEM) to assess national surveillance data for respiratory syncytial virus (RSV) in the Netherlands, 2005 to 2017

BACKGROUND: To control respiratory syncytial virus (RSV), which causes acute respiratory infections, data and methods to assess its epidemiology are important. AIM: We sought to describe RSV seasonality, affected age groups and RSV-type distribution over 12 consecutive seasons in the Netherlands, as...

Descripción completa

Detalles Bibliográficos
Autores principales: Vos, Laura M, Teirlinck, Anne C, Lozano, José E, Vega, Tomás, Donker, Gé A, Hoepelman, Andy IM, Bont, Louis J, Oosterheert, Jan Jelrik, Meijer, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530251/
https://www.ncbi.nlm.nih.gov/pubmed/31115311
http://dx.doi.org/10.2807/1560-7917.ES.2019.24.20.1800469
_version_ 1783420595388547072
author Vos, Laura M
Teirlinck, Anne C
Lozano, José E
Vega, Tomás
Donker, Gé A
Hoepelman, Andy IM
Bont, Louis J
Oosterheert, Jan Jelrik
Meijer, Adam
author_facet Vos, Laura M
Teirlinck, Anne C
Lozano, José E
Vega, Tomás
Donker, Gé A
Hoepelman, Andy IM
Bont, Louis J
Oosterheert, Jan Jelrik
Meijer, Adam
author_sort Vos, Laura M
collection PubMed
description BACKGROUND: To control respiratory syncytial virus (RSV), which causes acute respiratory infections, data and methods to assess its epidemiology are important. AIM: We sought to describe RSV seasonality, affected age groups and RSV-type distribution over 12 consecutive seasons in the Netherlands, as well as to validate the moving epidemic method (MEM) for monitoring RSV epidemics. METHODS: We used 2005−17 laboratory surveillance data and sentinel data. For RSV seasonality evaluation, epidemic thresholds (i) at 1.2% of the cumulative number of RSV-positive patients per season and (ii) at 20 detections per week (for laboratory data) were employed. We also assessed MEM thresholds. RESULTS: In laboratory data RSV was reported 25,491 times (no denominator). In sentinel data 5.6% (767/13,577) of specimens tested RSV positive. Over 12 seasons, sentinel data showed percentage increases of RSV positive samples. The average epidemic length was 18.0 weeks (95% confidence intervals (CI):  16.3–19.7) and 16.5 weeks (95% CI: 14.0–18.0) for laboratory and sentinel data, respectively. Epidemics started on average in week 46 (95% CI: 45–48) and 47 (95% CI:  46–49), respectively. The peak was on average in the first week of January in both datasets. MEM showed similar results to the other methods. RSV incidence was highest in youngest (0–1 and >1–2 years) and oldest (>65–75 and > 75 years) age groups, with age distribution remaining stable over time. RSV-type dominance alternated every one or two seasons. CONCLUSIONS: Our findings provide baseline information for immunisation advisory groups. The possibility of employing MEM to monitor RSV epidemics allows prospective, nearly real-time use of surveillance data.
format Online
Article
Text
id pubmed-6530251
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-65302512019-06-10 Use of the moving epidemic method (MEM) to assess national surveillance data for respiratory syncytial virus (RSV) in the Netherlands, 2005 to 2017 Vos, Laura M Teirlinck, Anne C Lozano, José E Vega, Tomás Donker, Gé A Hoepelman, Andy IM Bont, Louis J Oosterheert, Jan Jelrik Meijer, Adam Euro Surveill Research BACKGROUND: To control respiratory syncytial virus (RSV), which causes acute respiratory infections, data and methods to assess its epidemiology are important. AIM: We sought to describe RSV seasonality, affected age groups and RSV-type distribution over 12 consecutive seasons in the Netherlands, as well as to validate the moving epidemic method (MEM) for monitoring RSV epidemics. METHODS: We used 2005−17 laboratory surveillance data and sentinel data. For RSV seasonality evaluation, epidemic thresholds (i) at 1.2% of the cumulative number of RSV-positive patients per season and (ii) at 20 detections per week (for laboratory data) were employed. We also assessed MEM thresholds. RESULTS: In laboratory data RSV was reported 25,491 times (no denominator). In sentinel data 5.6% (767/13,577) of specimens tested RSV positive. Over 12 seasons, sentinel data showed percentage increases of RSV positive samples. The average epidemic length was 18.0 weeks (95% confidence intervals (CI):  16.3–19.7) and 16.5 weeks (95% CI: 14.0–18.0) for laboratory and sentinel data, respectively. Epidemics started on average in week 46 (95% CI: 45–48) and 47 (95% CI:  46–49), respectively. The peak was on average in the first week of January in both datasets. MEM showed similar results to the other methods. RSV incidence was highest in youngest (0–1 and >1–2 years) and oldest (>65–75 and > 75 years) age groups, with age distribution remaining stable over time. RSV-type dominance alternated every one or two seasons. CONCLUSIONS: Our findings provide baseline information for immunisation advisory groups. The possibility of employing MEM to monitor RSV epidemics allows prospective, nearly real-time use of surveillance data. European Centre for Disease Prevention and Control (ECDC) 2019-05-16 /pmc/articles/PMC6530251/ /pubmed/31115311 http://dx.doi.org/10.2807/1560-7917.ES.2019.24.20.1800469 Text en This article is copyright of the authors or their affiliated institutions, 2019. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Research
Vos, Laura M
Teirlinck, Anne C
Lozano, José E
Vega, Tomás
Donker, Gé A
Hoepelman, Andy IM
Bont, Louis J
Oosterheert, Jan Jelrik
Meijer, Adam
Use of the moving epidemic method (MEM) to assess national surveillance data for respiratory syncytial virus (RSV) in the Netherlands, 2005 to 2017
title Use of the moving epidemic method (MEM) to assess national surveillance data for respiratory syncytial virus (RSV) in the Netherlands, 2005 to 2017
title_full Use of the moving epidemic method (MEM) to assess national surveillance data for respiratory syncytial virus (RSV) in the Netherlands, 2005 to 2017
title_fullStr Use of the moving epidemic method (MEM) to assess national surveillance data for respiratory syncytial virus (RSV) in the Netherlands, 2005 to 2017
title_full_unstemmed Use of the moving epidemic method (MEM) to assess national surveillance data for respiratory syncytial virus (RSV) in the Netherlands, 2005 to 2017
title_short Use of the moving epidemic method (MEM) to assess national surveillance data for respiratory syncytial virus (RSV) in the Netherlands, 2005 to 2017
title_sort use of the moving epidemic method (mem) to assess national surveillance data for respiratory syncytial virus (rsv) in the netherlands, 2005 to 2017
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530251/
https://www.ncbi.nlm.nih.gov/pubmed/31115311
http://dx.doi.org/10.2807/1560-7917.ES.2019.24.20.1800469
work_keys_str_mv AT voslauram useofthemovingepidemicmethodmemtoassessnationalsurveillancedataforrespiratorysyncytialvirusrsvinthenetherlands2005to2017
AT teirlinckannec useofthemovingepidemicmethodmemtoassessnationalsurveillancedataforrespiratorysyncytialvirusrsvinthenetherlands2005to2017
AT lozanojosee useofthemovingepidemicmethodmemtoassessnationalsurveillancedataforrespiratorysyncytialvirusrsvinthenetherlands2005to2017
AT vegatomas useofthemovingepidemicmethodmemtoassessnationalsurveillancedataforrespiratorysyncytialvirusrsvinthenetherlands2005to2017
AT donkergea useofthemovingepidemicmethodmemtoassessnationalsurveillancedataforrespiratorysyncytialvirusrsvinthenetherlands2005to2017
AT hoepelmanandyim useofthemovingepidemicmethodmemtoassessnationalsurveillancedataforrespiratorysyncytialvirusrsvinthenetherlands2005to2017
AT bontlouisj useofthemovingepidemicmethodmemtoassessnationalsurveillancedataforrespiratorysyncytialvirusrsvinthenetherlands2005to2017
AT oosterheertjanjelrik useofthemovingepidemicmethodmemtoassessnationalsurveillancedataforrespiratorysyncytialvirusrsvinthenetherlands2005to2017
AT meijeradam useofthemovingepidemicmethodmemtoassessnationalsurveillancedataforrespiratorysyncytialvirusrsvinthenetherlands2005to2017